BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1398521)

  • 1. A major solid undifferentiated carcinoma pattern correlates with tumour progression in locally advanced prostatic carcinoma.
    Gaffney EF; O'Sullivan SN; O'Brien A
    Histopathology; 1992 Sep; 21(3):249-55. PubMed ID: 1398521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
    Feiner HD; Gonzalez R
    Am J Surg Pathol; 1986 Nov; 10(11):765-70. PubMed ID: 2430476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.
    Mohler JL; Figlesthaler WM; Zhang XZ; Partin AW; Maygarden SJ
    Cancer; 1994 Dec; 74(11):2996-3001. PubMed ID: 7954263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 immunohistochemical and genetic alterations are associated at high incidence with post-irradiated locally persistent prostate carcinoma.
    Prendergast NJ; Atkins MR; Schatte EC; Paulson DF; Walther PJ
    J Urol; 1996 May; 155(5):1685-92. PubMed ID: 8627854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine differentiation in prostatic carcinoma.
    di Sant'Agnese PA; de Mesy Jensen KL
    Hum Pathol; 1987 Aug; 18(8):849-56. PubMed ID: 3610135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
    Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR
    Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extent of apoptosis in different types of high grade prostatic carcinoma.
    Gaffney EF
    Histopathology; 1994 Sep; 25(3):269-73. PubMed ID: 7821895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.
    Lee S; Han JS; Chang A; Ross HM; Montironi R; Yorukoglu K; Lane Z; Epstein JI
    Hum Pathol; 2013 Mar; 44(3):427-31. PubMed ID: 23026197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma.
    Tardif CP; Partin AW; Qaqish B; Epstein JP; Mohler JL
    Anal Quant Cytol Histol; 1992 Dec; 14(6):474-82. PubMed ID: 1292446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathology of prostate carcinoma. Diagnosis and differential diagnosis.
    Dhom G
    Pathol Res Pract; 1985 Jan; 179(3):277-303. PubMed ID: 2580293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia.
    Humphrey PA; Swanson PE
    Pathol Res Pract; 1995 Sep; 191(9):881-7. PubMed ID: 8606869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthoma of the prostate: a mimicker of high-grade prostate adenocarcinoma.
    Chuang AY; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1225-30. PubMed ID: 17667547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
    Abrahamsson PA; Falkmer S; Fält K; Grimelius L
    Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.
    Montironi R; Lucarini G; Castaldini C; Galluzzi CM; Biagini G; Fabris G
    Anticancer Res; 1996; 16(4A):2057-62. PubMed ID: 8712742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoepithelioma-like carcinoma of the prostate.
    Lopez-Beltran A; Cheng L; Prieto R; Blanca A; Montironi R
    Hum Pathol; 2009 Jul; 40(7):982-7. PubMed ID: 19269013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of prostatic cancer.
    Hohbach C; Dhom G
    Scand J Urol Nephrol Suppl; 1980; 55():37-47. PubMed ID: 6938034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings.
    Gong Y; Caraway N; Stewart J; Staerkel G
    Am J Clin Pathol; 2006 Aug; 126(2):302-9. PubMed ID: 16891207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.